These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24533277)

  • 1. Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults?
    van Hellemond JJ; Molhoek N; Koelewijn R; Wismans PJ; van Genderen PJ
    Int J Parasitol Drugs Drug Resist; 2012 Dec; 2():162-5. PubMed ID: 24533277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment.
    Burgaña A; Abellana R; Yordanov SZ; Kazan R; Pérez Ortiz AM; Ramos CC; Hernández CG; Rivero MM; Gonçalves AQ; Padilla E; Pérez J; García-Puig R; Perez-Porcuna TM
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():95-100. PubMed ID: 31759244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is paromomycin the drug of choice for eradication of Blastocystis in adults?
    van Hellemond JJ; Molhoek N; Koelewijn R; Wismans PJ; van Genderen PJ
    J Infect Chemother; 2013 Jun; 19(3):545-8. PubMed ID: 23053509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dientamoeba fragilis in the North-East of Italy: Prevalence study and treatment.
    Clemente L; Pasut M; Carlet R; Ruscio M; Fontana F
    Parasitol Int; 2021 Feb; 80():102227. PubMed ID: 33137500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should Dientamoeba fragillis be looked for in pediatric digestive pathology of an unknown cause? A proposed pilot case-control study.
    Montraveta-Querol M; Bovo MV; Roig-Abraham N; Romaní N; Alcaraz A; Fernández-Rivas G
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Oct; 40(8):436-440. PubMed ID: 36195407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dientamoeba fragilis in children: a systematic review on diagnostic considerations and efficacy of treatment.
    van Kalleveen MW; van Gool T; Klarenbeek N; Benninga MA; Savelkoul PHM; de Meij T; Plötz FB
    Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):231-242. PubMed ID: 32155096
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiological and clinical characteristics of Dientamoeba fragilis infection.
    Menéndez C; Fernández-Suarez J; Boga Ribeiro JA; Rodríguez-Pérez M; Vázquez F; Gonzalez-Sotorrios N; Rodríguez-Guardado A
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37(5):290-295. PubMed ID: 30274823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dientamoeba fragilis and chronic abdominal pain in children: a case-control study.
    de Jong MJ; Korterink JJ; Benninga MA; Hilbink M; Widdershoven J; Deckers-Kocken JM
    Arch Dis Child; 2014 Dec; 99(12):1109-13. PubMed ID: 25053737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Dientamoeba fragilis cause diarrhea? A systematic review.
    Wong ZW; Faulder K; Robinson JL
    Parasitol Res; 2018 Apr; 117(4):971-980. PubMed ID: 29404747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the treatment of Enterobius vermicularis co-infection necessary to eradicate Dientamoeba fragilis infection?
    Boga JA; Rojo S; Fernández J; Rodríguez M; Iglesias C; Martínez-Camblor P; Vázquez F; Rodríguez-Guardado A
    Int J Infect Dis; 2016 Aug; 49():59-61. PubMed ID: 27263118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of
    Pietilä JP; Häkkinen TA; Pakarinen L; Ollgren J; Kantele A
    New Microbes New Infect; 2023 Sep; 54():101179. PubMed ID: 37786407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole.
    Chan FT; Guan MX; Mackenzie AM; Diaz-Mitoma F
    Antimicrob Agents Chemother; 1994 May; 38(5):1157-60. PubMed ID: 8067755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dientamoeba fragilis: possibly an important cause of persistent abdominal pain in children].
    Bosman DK; Benninga MA; van de Berg P; Kooijman GC; van Gool T
    Ned Tijdschr Geneeskd; 2004 Mar; 148(12):575-9. PubMed ID: 15074181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment options for Dientamoeba fragilis infections.
    Nagata N; Marriott D; Harkness J; Ellis JT; Stark D
    Int J Parasitol Drugs Drug Resist; 2012 Dec; 2():204-15. PubMed ID: 24533282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dientamoeba fragilis infection as cause of severe abdominal discomfort and flatulence].
    Halkjær S; Stensvold CR; Petersen AM
    Ugeskr Laeger; 2015 Jan; 177(2A):30-1. PubMed ID: 25612954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Dientamoeba fragilis infection with paromomycin.
    Vandenberg O; Souayah H; Mouchet F; Dediste A; van Gool T
    Pediatr Infect Dis J; 2007 Jan; 26(1):88-90. PubMed ID: 17195717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-controlled study of Dientamoeba fragilis infections in children.
    Banik GR; Barratt JL; Marriott D; Harkness J; Ellis JT; Stark D
    Parasitology; 2011 Jun; 138(7):819-23. PubMed ID: 21524324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical guideline on Dientamoeba fragilis infections.
    van Gestel RS; Kusters JG; Monkelbaan JF
    Parasitology; 2019 Aug; 146(9):1131-1139. PubMed ID: 30165915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mexican Honeymoon Marred by Gastrointestinal Upset: A Case of Dientamoeba fragilis Causing Post-infectious Irritable Bowel Syndrome.
    Ali S; Khetpal N; Khan MT; Rasheed M; Asad-Ur-Rahman F; Echeverria-Beltran K
    Cureus; 2017 Dec; 9(12):e1992. PubMed ID: 29503786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms and treatment of Dientamoeba fragilis infection in children, a retrospective study.
    Schure JM; de Vries M; Weel JF; van Roon EN; Faber TE
    Pediatr Infect Dis J; 2013 Apr; 32(4):e148-50. PubMed ID: 23190787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.